Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
Faessel Publishing LLC
Dr.Faessel@onthemar.com

Axion International Holdings, Inc. (AXIH) 2.90 OTCBB

And the chart is in a breakout

(AXIH) is a technology developer that produces a building material that doesn’t rot, rust or corrode and it’s more cost effective and longer lasting than wood, steel or concrete―and it’s 100% environmentally friendly. That’s a mouthful, but there’s even more bling; the material is made from common everyday plastic waste. The story is so good it resonates like an infomercial with a; “Wait, there’s more” tagline. Talk about a story with sizzle, this one really roars. Read the rest of this entry »

Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
Faessel Publishing LLC
Dr.Faessel@onthemar.com

E-18, Corp. (ETEN) $0.95 OTCBB 

The short and compelling story regarding E-18 Corp (ETEN) is that the company is offering a long-awaited, truly unique “safe needle” to the healthcare industry into a mammoth market at prices only modestly higher than conventional syringes. This “Holy-Grail” breakthrough has the potential for not only solving the problems of needlestick injuries that have for so long been the cause of dread in the healthcare workplace, but for gaining near immediate and significant market share and, importantly, for providing shareholders with a much-improved stock price. Read the rest of this entry »

Arthur Goldgaber
Market Analyst
SmallcapInsights.com

To view the PDF of this white paper, written by Market Analyst Arthur Goldgaber, please click here.

Arthur Goldgaber
Market Analyst
SmallcapInsights.com

To view the PDF of this white paper, written by Market Analyst Arthur Goldgaber, please click here.

Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
Faessel Publishing LLC
Dr.Faessel@onthemar.com

E-18, Corp. (ETEN) $1.01 OTCBB 

E-18 Corp (ETEN) is offering the long-awaited safety solution to the healthcare industry into a mammoth market at prices only modestly higher than conventional syringes …

As a healthcare professional who has given tens of thousands of injections I believe that the truly unique self-sheathing syringe developed by E-18, Corp. (ETEN) is a “Holy-Grail” breakthrough with the potential for not only gaining near immediate and significant market share, but for providing shareholders with a much-improved stock price. Read the rest of this entry »

The Editors
SmallcapInsights.com

If you could invest in a company that produces a patented, disposable medical device with a $5 billion market, and is the only one in its genre that meets the Federal Government’s stringent product mandate, thus requiring healthcare professionals to use it, would you take advantage of the opportunity? Oh, yes, and happens to be manufactured exclusively in the USA?

I’m betting yes. Read the rest of this entry »

The Editors
SmallcapInsights.com

The tricky part about recessions is that the head-in-the-sand approach doesn’t tend to work. Like a serious illness, a recession’s impact on a company has to be addressed early and the ongoing strategy, while perhaps amended, has to plan for post recession. The prognosis of not doing this is indeed dire for the ‘patient’. In this case the patient is the battle weary shareholder.

Let’s do a little background and follow it with a real-world example. Trust me, the latter is well worth the complete read. Read the rest of this entry »

Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
Faessel Publishing LLC
Dr.Faessel@onthemar.com

Beacon Enterprise Solutions Group, Inc. (BEAC) $1.17 OTCBB

(BEAC) closes on a major international acquisition

Adds “a minimum of $10 million in new revenue in FY 2010”

(BEAC) just announced that it has closed on an acquisition that will fire new and near immediate revenue opportunities. The deal expands (BEAC) internationally and brings to Europe and beyond what has proved to be a recession-proof business model that is delivering to clients “cost savings up to 30% and in some cases more.”

(BEAC) management’s recent and seemingly endless string of successfully closed service agreements (and upgrades) is exceptional. This compelling combination of management and business expansion together with yet a new deal moves me to upgrade the company to the top of my “Best Idea” list. Read the rest of this entry »

Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
Faessel Publishing LLC
Dr.Faessel@onthemar.com

(NXTH) announced research coverage by CHARLES PAYNE EQUITY RESEARCH. Mr. Payne’s two-year price target is $5.00.

NXT Nutritionals Holdings, Inc. (NXTH) $1.42 OTCBB

One week ago I introduced a new idea and I mentioned that, “the story falls into a category where if the stars align this company could have blistering upside potential.” Understanding the substance of deep space may be well beyond the scope of us mere earthlings, but the forces that propelled (NXTH) up over 35% in a week are better understood. To wit; it’s a flat-out terrific story, buyers undeniably showed their “hand” and the stock took-off. Now add Friday’s news that a well known Wall Street analyst and talking head has also embraced (NXTH)’s potential makes the outlook even more compelling for the shares. Read the rest of this entry »

Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
A Faessel Publishing LLC company
Dr.Faessel@onthemar.com

Beacon Enterprise Solutions Group, Inc. (BEAC) $1.73 OTCBB

Extraordinary results continue to stack-up for “Best Idea” (BEAC) since I first introduced the company in late April. Not only has the stock shot-up significantly from $0.75, but the company has signed a string of new service agreements with some of the largest companies in the world. I had pointed out that “upside and growth possibilities for undiscovered and undervalued Beacon appeared outstanding to me.”

Let’s reference Friday’s post-close press release contract update regarding a Department of Defense [DOD] contract as an example. Read the rest of this entry »